Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Aligos Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $39.33, which forecasts a 488.77% increase in the stock price over the next year. The lowest target is $20 and the highest is $50.

Price Target: $39.33 (+488.77%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$39.33	$48	$50
Change	+199.40%	+488.77%	+618.56%	+648.50%

* Price targets were last updated on Mar 19, 2026.

Analyst Ratings

The average analyst rating for Aligos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	3	3	4	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthea Li Jefferies	Jefferies	Strong Buy Initiates $60 → $48	Strong Buy	Initiates	$60 → $48	+618.56%	Mar 19, 2026
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+648.50%	Mar 11, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+199.40%	Jan 7, 2026
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+648.50%	Sep 12, 2025
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+648.50%	Aug 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.89M

Increased by 32.20%

from 2.19M

Revenue Next Year

3.03M

Increased by 4.71%

from 2.89M

EPS This Year

-7.29

from -2.45

EPS Next Year

-5.04

from -7.29

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	4.36M	13.91M	15.53M	3.95M	2.19M	2.89M	3.03M
Revenue Growth	-	219.04%	11.66%	-74.60%	-44.59%	32.20%	4.71%
EPS	-80.50	-56.25	-34.20	-20.94	-2.45	-7.29	-5.04
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	4.7M	5.1M
Avg	2.9M	3.0M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	116.1%	78.0%
Avg	32.2%	4.7%
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-5.89	-4.04
Avg	-7.29	-5.04
Low	-8.08	-7.43

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.